Clinical Trials
An experimental triple-hormone injection from Eli Lilly showing the biggest weight-loss results of any drug tested so far. Not yet approved — still in late-stage trials.
Fatty Liver Disease (NAFLD/MASH)
Research Phase
An investigational dual GLP-1/glucagon receptor agonist in Phase 3 trials, designed to combine appetite suppression with increased calorie burning.
FDA Approved
An FDA-approved weekly injection for diabetes and weight loss. Delivers the strongest results of any approved weight-loss medication to date.